Neprojeong (Calcium Acetate)

Adult dose

1) Initial dose: Take 2 tablets orally with each meal. 2) Maintenance dose: Gradually increase the dose until the serum phosphate concentration is 6mg/dl or lower, without causing hypercalcemia. Usually, take 3-4 tablets orally with meals.

This medication should not be used in patients with hypercalcemia. When taken, it may increase the calcium levels in the blood; in mild cases, there may be no symptoms, or symptoms such as constipation, loss of appetite, nausea, and vomiting may appear. In severe cases, serious symptoms such as confusion, sensory loss, and coma may occur, so caution is necessary. When starting treatment, it is important to establish an appropriate dose and adjust as needed, as overdose can increase the risk of hypercalcemia. Therefore, measuring blood calcium levels twice a week in the early stages of treatment is essential. Moreover, this medication may worsen cardiac arrhythmias, so it should not be administered to patients taking digitalis preparations. Regular monitoring of blood phosphate levels is also important, and the use of non-prescribed antacids is best avoided. This medication may reduce the effectiveness of tetracycline antibiotics, so caution is required when taken together. The effects of this medication on the fetus are not clearly established during pregnancy; it should only be used when the benefit outweighs the risk, and safety and efficacy have not been established in children. Finally, patients should be adequately informed to recognize the symptoms of hypercalcemia and take the necessary precautions.

• Hypercalcemia
• constipation
• loss of appetite
• nausea
• vomiting
• confusion
• sensory loss
• coma

Keep this medication in a tightly closed container to protect it from air and moisture. Additionally, store the medication away from direct sunlight at room temperature, avoiding extreme hot or cold temperatures.

Appearance

White, round tablets with a score line

Package unit

30 tablets/bottle, 300 tablets/bottle